Amlodipine versus diltiazem as additional antianginal treatment to atenolol

American Journal of Cardiology

Volumn 81, Issue 2, 1998, Pages 133-136

  Knight, Charles J ^a   Fox, Kim M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; GLYCERYL TRINITRATE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; EDEMA; EXERCISE TEST; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ST SEGMENT DEPRESSION; SUBLINGUAL DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION; SYNCOPE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; AMLODIPINE; ANGINA PECTORIS; ATENOLOL; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; DILTIAZEM; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; SAFETY; TREATMENT OUTCOME;

EID: 0032518840     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00893-X     Document Type: Article

References (17)

1. 1. Lehmann G, Reiniger G, Beyerle A, Rudolph W. Pharmacokinetics and additional anti-ischemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and long-term therapy of stable angina pectoris in patients pre-treated with a beta-blocker. Eur Heart J 1993;14:1531-1535.
2. 2. Boden WE, Bough EW, Reichman MJ, Rich VB, Young PM, Korr KS, Shulman RS. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study. Circulation 1985;71:1197-1205.
3. 3. Quyyumi AA, Mockus L, Wright C, Fox KM. Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease: investigation of the frequency of nocturnal ischemia and coronary spasm. Br Heart J 1985;53:186-193.
4. 4. Bruce RA, Hornstein TR. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 1969;11:371-390.
5. 5. Kenny J, Kiff P, Holmes J, Jewitt DE. Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris. Br Heart J 1985;53:43-46.
6. 6. Hung J, Lamb IH, Connolly SJ, Jutzy KR, Goris ML, Schroeder JS. The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study. Circulation 1983;68:560-567.
7. 7. Stone PH, Gibson RS, Glasser SP, DeWood MA, Parker JD, Kawanishi DT, Crawford MH, Messineo FC, Shook TL, Raby K. Comparison of propranolol, diltiazem and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation 1990;82:1962-1972.
8. 8. Deanfield JE, Detry J-M RG, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-ischemia Program in Europe (CAPE trial). J Am Coll Cardiol 1994;24:1460-1467.
9. 9. Morse JR. Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris. Am J Cardiol 1988;62:1028-1032.
10. 10. Robinson K, Krikler S, Krikler D. Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol. Am J Cardiol 1989;64:27F-30F.
11. 11. Meluzin J, Zeman K, Stetka F, Simek P. Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers. J Cardiovasc Pharmacol 1992;20:864-869.
12. 12. Siu SC, Jacoby RM, Phillips RT, Nesto RW. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta-blockers in stable angina pectoris. Am J Cardiol 1993;71:887-892.
13. 13. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748-756.
14. 14. Moss AJ, Goldstein RE, Hall WJ, Bigger JT Jr, Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. JAMA 1993;269:2379-2385.
15. 15. Mulcahy D, Knight C, Patel D, Curzen N, Cunningham D, Wright C, Clarke D, Purcell H, Sutton G, Fox K. Detection of ambulatory ischaemia is not of practical clinical value in the routine management of patients with stable angina. A long-term follow-up study. Eur Heart J 1995;16:317-324.
16. 16. Santarelli P, Biscione F, Natale A, Manzoli A, Lanza GA. Electrophysiological effects of amlodipine versus diltiazem in patients with coronary artery disease and beta-blocking therapy. Cardiovasc Drugs Ther 1994;8:653-658.
17. 17. O'Hara MJ, Khurmi NS, Bowles MJ, Raftery EB. Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris. Clin Cardiol 1987;10:115-123.